Ensign-Bickford Chooses Boomi to Reduce Costs While Improving Productivity, Work-Life Balance, and Customer Satisfaction
Global, diversified science and technology company uses the Boomi Enterprise Platform to manage unprecedented growth,…
Enterprise Resource Planning
Quantum Provides Additional Business Updates
SAN JOSE, Calif.–(BUSINESS WIRE)–Quantum Corporation (Nasdaq: QMCO), a leader in solutions for AI and unstructured…
Nerdio Unveils Major Upgrades in Nerdio Manager for Enterprise and Nerdio Manager for MSP, Enhancing Both Platforms
Nerdio releases new features infusing AI capabilities and streamlining management to elevate IT management in…
Wipro Announces Results for the Quarter-Ended December 31, 2023
IT services segment revenue near top-end of guidance Delivers IT services operating margin at 16%,…
How A Company Planning An Enterprise Tech Purchase Can Avoid Bias
By Chris Heard, Olive CEO and co-founder “As-a-service” models show 60% of buyers experience remorse…
Basilea announces FDA acceptance of New Drug Application for antibiotic ceftobiprole
Seeking approval for Staphylococcus aureus bacteremia (SAB), acute bacterial skin and skin structure infections (ABSSSI),…
Krystal Biotech Announces FDA Clearance of Investigational New Drug Application for KB408 for the Treatment of Type 1 Alpha-1 Antitrypsin Deficiency
• Orphan Drug Designation Granted to KB408 PITTSBURGH, Sept. 21, 2023 (GLOBE NEWSWIRE) — Krystal…
Krystal Biotech Announces FDA Clearance of Investigational New Drug Application for KB408 for the Treatment of Type 1 Alpha-1 Antitrypsin Deficiency
• Orphan Drug Designation Granted to KB408 PITTSBURGH, Sept. 21, 2023 (GLOBE NEWSWIRE) — Krystal…
Perficient to Demonstrate Cloud Migration Expertise at Oracle CloudWorld
SAINT LOUIS–(BUSINESS WIRE)–Perficient, Inc. (Nasdaq: PRFT) (“Perficient”), the leading global digital consultancy transforming the world’s…
Breakthrough: GeneType for Pancreatic Cancer, Melanoma, and Atrial Fibrillation Cleared for Australian Release
Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) Expands Reach of Revolutionary geneType Multi-Risk Test in…
Breakthrough: GeneType for Pancreatic Cancer, Melanoma, and Atrial Fibrillation Cleared for Australian Release
Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) Expands Reach of Revolutionary geneType Multi-Risk Test in…
FUNKO INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Funko, Inc. – FNKO
NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at…
SAP, OneRail, Kinaxis, Manhattan Associates and Other Supply Chain Leaders to Showcase Latest Innovations at Visibility 2023
FourKites partners are leveraging real-time supply chain visibility data to improve operations far beyond transportation…
Excision BioTherapeutics Announces Gene Therapy Publication of Pre-Clinical Data Supporting its First-in-Class CRISPR-Based Gene Therapy Candidate Designed to Functionally Cure HIV-1
Results demonstrate safety, biodistribution, and on-target editing of simian immunodeficiency virus (SIV) in non-human primates…
Excision BioTherapeutics Announces Gene Therapy Publication of Pre-Clinical Data Supporting its First-in-Class CRISPR-Based Gene Therapy Candidate Designed to Functionally Cure HIV-1
Results demonstrate safety, biodistribution, and on-target editing of simian immunodeficiency virus (SIV) in non-human primates…
Catalyst Pharmaceuticals Announces Multiple Abstracts on FYCOMPA® (Perampanel) from Eisai Co, Ltd., to be Presented at the 35th International Epilepsy Congress
CORAL GABLES, Fla., Aug. 14, 2023 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst”) (Nasdaq: CPRX),…
Catalyst Pharmaceuticals Announces Multiple Abstracts on FYCOMPA® (Perampanel) from Eisai Co, Ltd., to be Presented at the 35th International Epilepsy Congress
CORAL GABLES, Fla., Aug. 14, 2023 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst”) (Nasdaq: CPRX),…
Fortrea Reports Second Quarter 2023 Results and Provides Full-Year 2023 Guidance
For the three months ended June 30, 2023: Revenues of $793.0 million GAAP net income…
Fortrea Reports Second Quarter 2023 Results and Provides Full-Year 2023 Guidance
For the three months ended June 30, 2023: Revenues of $793.0 million GAAP net income…
HireRight Reports Second Quarter 2023 Results
– $192 million in Revenues – – Increasing Full-Year Adjusted EBITDA Outlook – – Repurchased…